ResMed Inc. (RMD) NYSE
182.82
-3.62(-1.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
182.82
-3.62(-1.94%)
Currency In USD
| Previous Close | 186.44 |
| Open | 182.78 |
| Day High | 184.84 |
| Day Low | 180.27 |
| 52-Week High | 293.81 |
| 52-Week Low | 180.27 |
| Volume | 1.41M |
| Average Volume | 1.26M |
| Market Cap | 26.52B |
| PE | 17.63 |
| EPS | 10.37 |
| Moving Average 50 Days | 215.72 |
| Moving Average 200 Days | 248.54 |
| Change | -3.62 |
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
GlobeNewswire Inc.
Mar 03, 2026 8:00 AM GMT
Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise.Over half
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
GlobeNewswire Inc.
Feb 24, 2026 2:00 PM GMT
Center to Create Local Jobs and Strengthen U.S. Healthcare Supply ResilienceSAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home,
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
GlobeNewswire Inc.
Jan 08, 2026 9:05 PM GMT
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Excha